Ligand Pharmaceuticals Shares - Nasdaq price snapshot
20.06.2026 - 20:28:00 | ad-hoc-news.de
Edited by ad hoc news Saturday Desk. Verified prior to publication on 06/20/2026, 20:26 UTC. Details in the imprint.
Ligand Pharmaceuticals (US53220K1060) trade on Nasdaq, and the live results available for this run do not show a fresh company-specific catalyst. The latest verified quote places LGND at $273.81.
All news and analysis on Ligand Pharmaceuticals shares
Use this topic page to track verified updates, quote data, and company coverage in one place.
What the quote shows
LGND traded at $273.81 in the verified live quote used for this article. The OKX quote page lists Nasdaq as the venue and shows a 24-hour move of -0.39%.
Market context today
No fresh company-specific hook was live-verifiable in the available results, so the article uses a quiet-day market snapshot. That keeps the focus on the stock itself, the venue, and the latest verified price.
What the company sells
Ligand Pharmaceuticals is a biotech company built around royalty-generating drug assets and licensing. Its portfolio approach centers on partnered programs rather than a single consumer product.
Where the stock trades today
The shares of Ligand Pharmaceuticals (US53220K1060) trade on Nasdaq at $273.81 as of 06/20/2026, 20:26 UTC.
Ligand Pharmaceuticals at a glance
- Company: Ligand Pharmaceuticals Incorporated
- ISIN: US53220K1060
- Ticker: LGND
- Venue: Nasdaq
- Price (as of 06/20/2026, 20:26 UTC): $273.81
- Sector / Industry: Health Care / Biotechnology
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
